CFA
GILD icon

Cahill Financial Advisors’s Gilead Sciences GILD Stock Holding History

Cahill Financial Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$518K Buy
3,717
+38
+1% +$5.32K 0.06% 174
2025
Q4 		$452K Sell
3,679
-22
-0.6% -$2.67K 0.05% 185
2025
Q3 		$411K Buy
3,701
+73
+2% +$8.3K 0.05% 194
2025
Q2 		$402K Buy
3,628
+3
+0.1% +$319 0.05% 195
2025
Q1 		$406K Buy
3,625
+3
+0.1% +$310 0.06% 189
2024
Q4 		$335K Buy
+3,622
New +$326K 0.05% 201
2021
Q4 		– Sell
-860
Closed -$60K – 431
2021
Q3 		$60K Buy
+860
New +$60.4K 0.01% 318

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Cahill Financial Advisors's GILD Position: Q1 2026 in Review

Cahill Financial Advisors increased its Gilead Sciences (GILD) stake by 1% in Q1 2026, buying an estimated $5.32K and bringing the position to 3,717 shares worth $518K. The position accounts for 0.06% of the portfolio, ranked #174.

Cahill Financial Advisors first reported a position in GILD in Q3 2021 and has held it in 7 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Cahill Financial Advisors held 3,717 shares of Gilead Sciences worth $518K as of Q1 2026.
  • Cahill Financial Advisors bought 38 Gilead Sciences shares in Q1 2026, an estimated $5.32K.
  • Gilead Sciences made up 0.06% of Cahill Financial Advisors's portfolio in Q1 2026, its #174 holding.
  • Cahill Financial Advisors first reported a position in Gilead Sciences in Q3 2021 and has held it in 7 quarters since.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Cahill Financial Advisors's 13F filing for Q1 2026, filed 13 May 2026.